Advertisement

U.S. Markets closed

S&P Futures
6,002.00
-1.75(-0.03%)
Dow Futures
43,893.00
-17.00(-0.04%)
Nasdaq Futures
21,222.25
-2.50(-0.01%)
Russell 2000 Futures
2,396.70
+1.00(+0.04%)
Crude Oil
71.91
-0.45(-0.62%)
Gold
2,704.40
-1.40(-0.05%)

Genenta Science S.p.A. (GNTA)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD

4.8600

+0.0300

(+0.62%)

At close: 04:00PM EST

Loading interactive chart...

GlobeNewswire
Genenta’s CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective”
MILAN and NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a pioneer in immuno-oncology and in cell-based therapeutics, is pleased to announce that Pierluigi Paracchi, CEO, will attend as a speaker to the Italy-U.S. meeting “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective” scheduled at 2.00 PM on October 25th, 2024 at the U.S. Senate - Washington, D.C. The event is organized by the U.S. National Security Commission on Em
Simply Wall St.
Genenta Science S.p.A.'s (NASDAQ:GNTA) market cap rose US$46m last week; individual investors who hold 55% profited and so did insiders
Key Insights The considerable ownership by individual investors in Genenta Science indicates that they collectively...